Mouse mTOR Ready-To-Use IHC Kit Size:50 Test and other neuro-endocrine tumors

and other neuro-endocrine tumors

Conjugation None Clone# Veltuzumab Formulation 100 mM Pro-Ac 20mM Arg pH 5

2010306G03Rik

Number Component 50T Concentration Storage 1 PBS Buffer (powder) 2L x 2 20x RT 2 Antigen Retrieval Buffer 20ml 100x 2-8°C 3 Endogenous Peroxidase Blocking Buffer 3ml RTU 2-8°C 4 Blocking Buffer 3ml RTU 2-8°C 5 "Primary Antibody (Mouse VCP Recombinant Rabbit mAb)" 6ml RTU 2-8°C 6 "Secondary Antibody (Goat Anti-Rabbit IgG H&L

Number Component 50T Concentration Storage 1 PBS Buffer (powder) 2L x 2 20x RT 2 Antigen Retrieval Buffer 20ml 100x 2-8°C 3 Endogenous Peroxidase Blocking Buffer 3ml RTU 2-8°C 4 Blocking Buffer 3ml RTU 2-8°C 5 Primary Antibody (Human Cyclin D1 Recombinant Rabbit mAb) 6ml RTU 2-8°C 6 Secondary Antibody (Goat Anti-Rabbit IgG H&L

Mouse mTOR Ready-To-Use IHC Kit Size:50 Test and other neuro-endocrine tumorsMouse mTOR Ready To Use IHC Kit Cat. No.: IHC0476M Sample Type: FFPE tissue Size: 50T (including a control slide) Storage and Stability: Please store components at the temperatures indicated on the individual tube labels. The kit is stable for 6 months from the date of receipt. Background FRAP1 (mTOR) is a serine threonine kinase that plays a critical role in cellular growth and proliferation. Perturbations in the mTOR PI3 kinase AKT pathway are